India's Avesthagen has inked a deal to use Affymetrix's microarray technology in a genetic study involving 60,000 Parsi. The Avestagenome Project is studying the genetic foundation behind longevity. Almost a third of the Parsi population lives beyond the age of 60, compared to seven percent of the country's entire population.
- see this release
- read the story in the San Jose Business Journal
Affymetrix to acquire ParAllele in $120M deal. Report
Longevity gene may be key to living past 100. Report
Biotechs pursue anti-aging treatments. Report